Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Inflammatory disease biotech pursues unprecedented combination of drug development and Ethereum treasury management In an unusual move for biotechnology, 180 Life Sciences announced a massive
Series B funding supports programmable mRNA platform with lead candidate showing promise in solid tumors Massachusetts-based Strand Therapeutics completed a $153 million Series B financing
Multi-year partnership leverages AI analytics to improve treatment outcome modeling AstraZeneca expanded its collaboration with health data firm SOPHiA GENETICS to harness AI-powered “Multimodal Analytics
Exclusive U.S. licensing deal aims to reshape colorectal cancer screening landscape Exact Sciences secured exclusive U.S. commercialization rights to Freenome’s blood-based colorectal cancer screening test
Belgian specialty pharma gains pediatric cancer franchise and FDA priority review voucher Belgian specialty pharmaceutical company SERB Pharmaceuticals announced an all-cash $412 million acquisition of
Vepdegestrant PROTAC estrogen receptor degrader targets ER+ breast cancer with novel mechanism The FDA accepted Arvinas and Pfizer’s New Drug Application for vepdegestrant (ARV-471), granting
Melanoma vaccine combination shows numerical benefit but misses primary endpoint, shares plummet 34% IO Biotech’s Phase 3 trial evaluating its IO102/IO103 therapeutic cancer vaccine (Cylembio)
Thermo Fisher’s companion diagnostic enables precision treatment with zongertinib for rare NSCLC subset The FDA approved Thermo Fisher Scientific’s Oncomine Dx Target Test as a
